clonidine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 5 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Specifically, we assessed clonidine dosage in relation to a) plasma concentration levels, b) orthostatic cardiovascular responses, and c) possible adverse effects." | 2.77 | Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial. ( Andersen, AM; Fagermoen, E; Saul, JP; Sulheim, D; Thaulow, E; Vethe, NT; Winger, A; Wyller, VB, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sulheim, D | 4 |
| Fagermoen, E | 4 |
| Winger, A | 4 |
| Andersen, AM | 3 |
| Godang, K | 2 |
| Müller, F | 1 |
| Rowe, PC | 2 |
| Saul, JP | 4 |
| Skovlund, E | 2 |
| Øie, MG | 1 |
| Wyller, VB | 4 |
| Gjerstad, J | 2 |
| Hall, KT | 1 |
| Kossowsky, J | 1 |
| Oberlander, TF | 1 |
| Kaptchuk, TJ | 1 |
| Mukamal, KJ | 1 |
| Vethe, NT | 1 |
| Thaulow, E | 1 |
| Morriss, RK | 1 |
| Robson, MJ | 1 |
| Deakin, JF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial[NCT01040429] | Phase 2 | 120 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| Pilot Study for the NorCAPITAL Trial[NCT01507701] | 5 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for clonidine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; C-Reactive Protein; Clonidine; Creatinine; Cross-S | 2014 |
Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Clonidine; Creatinine; Double-Blind Method; Epinep | 2015 |
Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Catechol O-Methyltransferase; Child; Clonidine; Do | 2016 |
Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial.
Topics: Adolescent; Clonidine; Fatigue Syndrome, Chronic; Female; Hemodynamics; Humans; Male; Norway; Pilot | 2012 |
Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial.
Topics: Adolescent; Clonidine; Fatigue Syndrome, Chronic; Female; Hemodynamics; Humans; Male; Norway; Pilot | 2012 |
Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial.
Topics: Adolescent; Clonidine; Fatigue Syndrome, Chronic; Female; Hemodynamics; Humans; Male; Norway; Pilot | 2012 |
Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial.
Topics: Adolescent; Clonidine; Fatigue Syndrome, Chronic; Female; Hemodynamics; Humans; Male; Norway; Pilot | 2012 |
Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Analysis of Variance; Area Under Curve; Arousal; Clonid | 2002 |